Megace ES News

Alfacell Deals US Rights for Onconase to Strativa - BioWorld Online

Inc. So far, Strativa markets just one product: Megace ES for anorexia, cachexia and unexplained weight loss in HIV patients. Although the company has deals ...

http://www.bioworld.com/servlet/c... | Posted: Tue Jan 15 20:54:58 -0500 2008

Par Pharmaceutical Files Form 10-Qs for First and Second Quarters ... - Earthtimes

Sales of Megace(R) ES (megestrol acetate) oral suspension increased 124 percent to $19.1 million in the second quarter. Par's second-quarter gross margin ...

http://www.earthtimes.org/article... | Posted: Wed Nov 21 06:03:16 -0500 2007

Par Pharmaceutical Provides Summary of Analyst/Investor Day - PR Newswire (press release)

... 8 potential first-to-file ANDA submissions -- Terminated certain non-core assets -- 9 generic product launches -- Megace ES(R) sales annualizing at over ...

http://www.prnewswire.com/cgi-bin... | Posted: Fri Sep 28 06:31:57 -0400 2007

Introducing Strativa Pharmaceuticals - Earthtimes.org

Megace ES generated more than $19 million in net sales in the second quarter of 2007. Megace ES sales are currently annualizing at over $75 million. ...

http://www.earthtimes.org/article... | Posted: Fri Sep 28 07:05:19 -0400 2007

Par Pharmaceutical Licenses Commercialization Rights to ... - Earthtimes.org

With Megace(R) ES and pafuramidine, Par's sales force would be helping to address two of the most life-threatening diseases afflicting HIV/AIDS patients ...

http://www.earthtimes.org/article... | Posted: Tue Jun 12 05:24:19 -0400 2007

Megace ES

Post a new Megace ES Side Effect

Ask a Question about Megace ES

All Megace ES Questions

Megace ES in the News

Add Megace ES to my cabinet

Megace ES Home Page

All Megace ES Side Effects

Megace ES RSS Feed

Frequently Reported Side Effects of Megace ES

immune system, ml, megace, appetite